SynthesisFrontiers in microbiology2025
Bile microbiota in gallbladder stones and its association with
Synthesis in Frontiers in microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Gallbladder stones (GS) is a prevalent gallstone disease. Recent studies indicate that bile microbiota dysregulation may contribute to their pathogenesis. However, the specific microbial alterations and their differences from gut microbiota patterns remain unclear. This study aimed to systematically evaluate the association between bile microbiota composition and GS. Methods: Eligible studies comparing bile microbiota profiles between patients with GS and non-GS controls were retrieved from eight databases. Data on Results: For Conclusion: GS is associated with bile microbiota dysbiosis, characterized by increased richness and potential overrepresentation of dominant taxa. These alterations differ from gut microbiota patterns in GS, suggesting a unique role of bile microbiota in GS pathogenesis. Systematic review registration: https://www.crd.york.ac.uk/prospero/, identifier CRD420251028569.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.